or Try an Advanced Search...

    Technical Analysis for GRI - GRI Bio, Inc.

    Grade Last Price % Change Price Change
    C 1.10 25.28% 0.22
    GRI closed up 25.28 percent on Friday, November 1, 2024, on 6.42 times normal volume.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical GRI trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Parabolic Rise Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Wide Bands Range Expansion 25.28%
    Gapped Down Weakness 25.28%
    Older End-of-Day Signals for GRI ...

       Recent Intraday Alerts

    Alert Time
    Upper Bollinger Band Resistance 1 day ago
    Rose Above Previous Day's High 1 day ago
    Rose Above Upper Bollinger Band 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    GRI Chart by TradingView
    Basic chart:

    Profile

    GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell

    Is GRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
    Oct 21 GRI Bio Announces Exercise of Warrants
    Oct 16 GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
    Oct 7 GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis
    Sep 30 GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions
    Sep 26 GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia
    Sep 25 GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
    Sep 18 GRI Bio Participates in Virtual Investor KOL Connect Segment
    Sep 5 GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Sep 4 GRI Bio to Present at the 2024 European Respiratory Congress
    See more GRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 134.68
    52 Week Low 0.3034
    Average Volume 5,227,155
    200-Day Moving Average 5.64
    50-Day Moving Average 0.54
    20-Day Moving Average 0.65
    10-Day Moving Average 0.87
    Average True Range 0.21
    RSI (14) 65.03
    ADX 31.61
    +DI 48.33
    -DI 13.80
    Chandelier Exit (Long, 3 ATRs) 1.16
    Chandelier Exit (Short, 3 ATRs) 0.95
    Upper Bollinger Bands 1.19
    Lower Bollinger Band 0.11
    Percent B (%b) 0.92
    BandWidth 166.73
    MACD Line 0.11
    MACD Signal Line 0.07
    MACD Histogram 0.0353
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.75
    Resistance 3 (R3) 1.76 1.55 1.64
    Resistance 2 (R2) 1.55 1.39 1.55 1.60
    Resistance 1 (R1) 1.33 1.29 1.44 1.32 1.57
    Pivot Point 1.12 1.12 1.18 1.12 1.12
    Support 1 (S1) 0.90 0.96 1.01 0.88 0.63
    Support 2 (S2) 0.69 0.86 0.69 0.60
    Support 3 (S3) 0.47 0.69 0.56
    Support 4 (S4) 0.45